PL4257122T3 - Liofilizat treosulfanu - Google Patents

Liofilizat treosulfanu

Info

Publication number
PL4257122T3
PL4257122T3 PL23192810.2T PL23192810T PL4257122T3 PL 4257122 T3 PL4257122 T3 PL 4257122T3 PL 23192810 T PL23192810 T PL 23192810T PL 4257122 T3 PL4257122 T3 PL 4257122T3
Authority
PL
Poland
Prior art keywords
treosulfan
lyophilisate
treosulfan lyophilisate
Prior art date
Application number
PL23192810.2T
Other languages
English (en)
Inventor
Sebastian Bialleck
Original Assignee
Medac Gesellschaft für klinische Spezialpräparate mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Gesellschaft für klinische Spezialpräparate mbH filed Critical Medac Gesellschaft für klinische Spezialpräparate mbH
Publication of PL4257122T3 publication Critical patent/PL4257122T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL23192810.2T 2018-09-26 2019-09-25 Liofilizat treosulfanu PL4257122T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18196967 2018-09-26

Publications (1)

Publication Number Publication Date
PL4257122T3 true PL4257122T3 (pl) 2026-06-29

Family

ID=63685769

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19778493.7T PL3856151T3 (pl) 2018-09-26 2019-09-25 Liofilizat treosulfanu
PL23192810.2T PL4257122T3 (pl) 2018-09-26 2019-09-25 Liofilizat treosulfanu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL19778493.7T PL3856151T3 (pl) 2018-09-26 2019-09-25 Liofilizat treosulfanu

Country Status (16)

Country Link
US (1) US12178914B2 (pl)
EP (2) EP4257122B1 (pl)
JP (3) JP7776985B2 (pl)
CN (1) CN112752569B (pl)
CA (1) CA3113705A1 (pl)
DK (2) DK3856151T3 (pl)
EA (1) EA202190616A1 (pl)
ES (2) ES2964602T3 (pl)
FI (2) FI4257122T3 (pl)
HR (1) HRP20231343T1 (pl)
HU (1) HUE064508T2 (pl)
LT (1) LT3856151T (pl)
PL (2) PL3856151T3 (pl)
PT (2) PT4257122T (pl)
SI (1) SI4257122T1 (pl)
WO (1) WO2020064819A1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891466A (en) 1958-04-24 1962-03-14 Nat Res Dev New methane sulphonic acid esters of polyols
DE1188583B (de) 1960-02-22 1965-03-11 Leo Pharm Prod Ltd Verfahren zur Herstellung der Steroisomeren und des Racemats von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat)
GB896052A (en) * 1960-02-22 1962-05-09 Knud Abildgaard The stereo-isomers and the racemate of butane-1,2,3,4-tetrol-1,4-di-(methanesulphonate)
DE1193938B (de) 1961-10-02 1965-06-03 Leo Pharm Prod Ltd Verfahren zur Herstellung des Racemats und der Stereoisomeren einschliesslich des Mesoisomeren von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat)
DE19936281C2 (de) 1999-08-02 2002-04-04 Bayer Ag Verfahren zur Gefriertrocknung
DE19953517C1 (de) 1999-11-05 2001-08-09 Medac Klinische Spezialpraep Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
US8793895B2 (en) 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
AR077384A1 (es) 2010-07-05 2011-08-24 Eriochem Sa Una formulacion farmaceutica inyectable de melfalano.
WO2014127802A1 (en) 2013-02-19 2014-08-28 Synthon Bv Stable compositions of bendamustine
IN2013MU03491A (pl) 2013-11-04 2015-07-31 Emcure Pharmaceuticals Ltd

Also Published As

Publication number Publication date
HRP20231343T1 (hr) 2024-02-16
CA3113705A1 (en) 2020-04-02
ES3071226T3 (en) 2026-06-22
DK3856151T3 (da) 2023-11-27
PT3856151T (pt) 2023-10-27
HUE064508T2 (hu) 2024-03-28
EP3856151B1 (en) 2023-08-23
LT3856151T (lt) 2023-11-27
ES2964602T3 (es) 2024-04-08
JP7776985B2 (ja) 2025-11-27
SI4257122T1 (sl) 2026-07-31
EP4257122A2 (en) 2023-10-11
JP2023153362A (ja) 2023-10-17
CN112752569B (zh) 2025-07-04
JP2022509904A (ja) 2022-01-25
EA202190616A1 (ru) 2021-06-25
DK4257122T3 (da) 2026-06-15
FI4257122T3 (fi) 2026-05-21
FI3856151T3 (fi) 2023-11-15
EP3856151A1 (en) 2021-08-04
EP4257122B1 (en) 2026-03-11
US12178914B2 (en) 2024-12-31
CN112752569A (zh) 2021-05-04
EP4257122A3 (en) 2024-01-10
PL3856151T3 (pl) 2024-02-19
PT4257122T (pt) 2026-06-08
JP2025137705A (ja) 2025-09-19
WO2020064819A1 (en) 2020-04-02
US20220031620A1 (en) 2022-02-03